Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Nature Careers
- DAAD
- Heidelberg University
- ;
- University of Antwerp
- University of Pittsburgh
- Duke University
- Hannover Medical School •
- SciLifeLab
- University of Adelaide
- University of Cambridge
- University of Sheffield
- University of Southern Denmark
- VIB
- ; Aston University
- ; Newcastle University
- ; University of Oxford
- Aalborg University
- Leibniz
- Leiden University
- Max Planck Institute of Immunobiology and Epigenetics •
- Max Planck Institute of Molecular Plant Physiology •
- McGill University
- Monash University
- Purdue University
- Technical University of Munich
- The Ohio State University
- Trinity College Dublin
- University of Alabama at Birmingham
- University of Freiburg •
- University of Groningen
- University of Göttingen •
- University of Luxembourg
- University of Maryland
- University of Maryland, Baltimore
- University of Massachusetts Medical School
- University of Nebraska Medical Center
- University of Newcastle
- University of Tübingen
- University of Tübingen •
- University of Vienna
- 31 more »
- « less
-
Field
-
-specific alpha-synuclein A30P human mutation, we will employ electrophysiological techniques, RNA sequencing, proteomics, and histochemical analysis. The findings are expected to provide insights into early
-
understood. Recent advances in omics technologies—genomics, transcriptomics, proteomics, metabolomics, and epigenomics—offer a powerful, integrative approach to comprehensively dissect the molecular landscape
-
at the intersection of machine learning, bioinformatics, and computational pathology. Project Overview: Integrating histopathological imaging with omics (e.g., transcriptomics, genomics, proteomics) holds tremendous
-
Mass Spectrometry and Systems Biology research unit’ at BMB and the ‘Danish National Mass Spectrometry Platform for Proteomics and Biomolecular Imaging’ (PLATO), which provides a highly international
-
Investigational Chemotherapy Service (ICS), Home Health infusion team and the Duke Metabolomics and Proteomics Institute (DMPI) will be required. · Ongoing engagement with the Food and Drug Administration (FDA
-
facilities (e.g., single-cell platforms, sequencing, proteomics and bioimaging) and extensive expertise in functional genomics, single-cell analyses, gene-regulatory mechanisms and cancer biology. This
-
), immunoblotting, ELISAs, RT-qPCR, EV analysis, multiplex analyses, and immunocytochemistry. Additionally, the candidate will need proficiency in analyzing and interpreting -omic datasets (metabolomics, proteomics
-
preferred) Strong background in cell culture and in vitro assays Experience with omics analyses such as proteomics by MS and transcriptome by RNA seq Strong data organization, management, and analysis skills
-
facilities (sequencing, proteomics and metabolomics). This dynamic setting fosters innovation and teamwork, enabling cutting-edge discoveries in the field of microbiome studies. The candidate will work on a
-
for growth and flux control. Engineering and optimization of microbial strains for production of bio-based products. Integration of metabolomics (targeted and untargeted), transcriptomics and proteomics